Virology News and Research

Latest Virology News and Research

Confidence in government may play key role in public's willingness to take swine flu vaccine

A new study suggests that confidence in government may play a key role in the public's willingness to get at least some vaccine

9 Feb 2015

ACEP: Emergency rooms are fully prepared to handle measles outbreak

The nation is dealing with the worst measles outbreak in more than a decade. Once again — and reminiscent of the recent Ebola crisis — the nation's emergency physicians are working to track and treat another infectious disease in the midst of a severe flu season.

6 Feb 2015

Chemotherapy or immunosuppressive treatment may reactivate HBV

Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease according to a summary of report from the Emerging Trends Conference, "Reactivation of Hepatitis B," and published in Hepatology, a journal of the American Association for the Study of Liver Diseases.

6 Feb 2015

Johns Hopkins researchers reveal that e-cigarettes weaken immune system

In a study with mice, Johns Hopkins Bloomberg School of Public Health researchers have found that e-cigarettes compromise the immune system in the lungs and generate some of the same potentially dangerous chemicals found in traditional nicotine cigarettes.

5 Feb 2015

Johns Hopkins researchers successfully deliver new nanoparticle gene therapy to treat glioma in rats

Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it's very difficult to effectively deliver toxic or missing genes to cancer cells in the brain.

5 Feb 2015

Epidemiologist urges people to get vaccinated against measles

Americans may be victims of their own success when it comes to the eradication of infectious diseases and take their disease-free lives for granted, says Jorge Parada, MD, hospital epidemiologist and medical director of the Infection Prevention and Control program at Loyola University Health System.

4 Feb 2015

Researchers suggest novel concept for developing vaccines against HIV and cancer

A experimental trial has shown successful by inducing serum in mice and has been highly neutralizing towards those ailments.

4 Feb 2015

Researchers offer critical new information about head and neck squamous cell cancer

Head and neck squamous cell cancer (HNSCC) ranks among the top ten most prevalent cancers in the United States. Despite its prevalence, little is known about how this cancer develops and spreads. However, in a paper published in the January 29, 2015 edition of Nature, researchers offer critical new information about head and neck cancers.

4 Feb 2015

BioMed Realty Trust expands footprint in Seattle's core innovation district of South Lake Union

BioMed Realty Trust, Inc. today announced that it is under contract to acquire the 307 Westlake Avenue North building in the heart of the burgeoning South Lake Union life science market of Seattle, Washington for approximately $90 million.

4 Feb 2015

Anti-viral immune cells could inhibit bone marrow transplant infections caused by CMV

Bone marrow transplantation is a life-saving therapy for patients with blood cancers like leukemia or lymphoma. However, the depletion of the patient's immune system prior to transplantation can put patients at risk of for an infection by a virus called cytomegalovirus (CMV) that can be life threatening in these immune-compromised individuals.

4 Feb 2015

New study helps explain how booster shots trigger immune 'memory' to improve

The last time you were in the doctor's office for a vaccine booster shot, did you wonder why you needed one? Exactly how booster shots offer long-term protection from viruses has long been a mystery to scientists.

3 Feb 2015

Using NMR to study influenza and TB: an interview with Dr. Tim Cross

In this interview, Tim Cross, Director of the NMR and MRI programs at the National High Magnetic Field Lab (NHMFL) in Tallahassee, Florida, talks about his research into protein structures in viruses and bacteria, and how the findings will affect medical research into disease prevention.

From Bruker BioSpin - NMR, EPR and Imaging 3 Feb 2015

Large clinical trial to assess safety, efficacy of two experimental Ebola vaccines opens in Liberia

A large clinical trial to assess the safety and efficacy of two experimental vaccines to prevent Ebola virus infection is now open to volunteers in Liberia. The trial is being led by a recently formed Liberia-U.S. clinical research partnership and is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

3 Feb 2015

ABIVAX doses first HIV positive patient in ABX464 Phase IIa clinical trial

ABIVAX, a leading clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, today announced that enrolment has been initiated and the first HIV positive patient dosed in a Phase IIa clinical trial of ABX464.

2 Feb 2015

Scientists identify how 'mini-brain' in spinal cord helps keep our body balanced

Walking across an icy parking lot in winter--and remaining upright--takes intense concentration. But a new discovery suggests that much of the balancing act that our bodies perform when faced with such a task happens unconsciously, thanks to a cluster of neurons in our spinal cord that function as a "mini-brain" to integrate sensory information and make the necessary adjustments to our muscles so that we don't slip and fall.

2 Feb 2015

Drug-resistant HIV viruses can spread rapidly, shows study

Drug-resistant HIV viruses can spread rapidly. This is the conclusion of a study conducted as part of the SWISS HIV Cohort Study, which is supported by the SNSF. Only the continuous introduction of new drugs can stop the virus from getting the upper hand.

2 Feb 2015

Researchers gain new insight on immune cells that harbor latent HIV virus

Drugs for HIV have become adept at suppressing infection, but they still can't eliminate it. That's because the medication in these pills doesn't touch the virus' hidden reserves, which lie dormant within infected white blood cells. Unlock the secrets of this pool of latent virus, scientists believe, and it may become possible to cure - not just control - HIV.

2 Feb 2015

Virology News and Research

Latest Virology News and Research

Confidence in government may play key role in public's willingness to take swine flu vaccine

ACEP: Emergency rooms are fully prepared to handle measles outbreak

Chemotherapy or immunosuppressive treatment may reactivate HBV

Johns Hopkins researchers reveal that e-cigarettes weaken immune system

Johns Hopkins researchers successfully deliver new nanoparticle gene therapy to treat glioma in rats

Epidemiologist urges people to get vaccinated against measles

Researchers suggest novel concept for developing vaccines against HIV and cancer

Researchers offer critical new information about head and neck squamous cell cancer

BioMed Realty Trust expands footprint in Seattle's core innovation district of South Lake Union

Anti-viral immune cells could inhibit bone marrow transplant infections caused by CMV

New study helps explain how booster shots trigger immune 'memory' to improve

Using NMR to study influenza and TB: an interview with Dr. Tim Cross

Large clinical trial to assess safety, efficacy of two experimental Ebola vaccines opens in Liberia

ABIVAX doses first HIV positive patient in ABX464 Phase IIa clinical trial

Scientists identify how 'mini-brain' in spinal cord helps keep our body balanced

Drug-resistant HIV viruses can spread rapidly, shows study

Researchers gain new insight on immune cells that harbor latent HIV virus

Immunization can prevent measles

Cities with Super Bowl teams see big spike in flu illness, deaths

Blood tests for Chikungunya virus and rheumatoid arthritis could produce similar results

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production